Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGA

Cancer News

Research paper from The Journal of Urology curated by Editor in Chief George Lundberg, MD, who notes: 

In this study, clinical and basic pathologic findings outperformed molecular typing in predicting outcomes of bladder cancer.

Go to full paper published in The Journal of Urology.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

Back to Cancer Insights